Development of Autoimmune Hair Loss Disease Alopecia Areata Is Associated with Cardiac Dysfunction in C3H/HeJ Mice

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Wang, Eddy ^a   Chong, Katy ^a   Yu, Mei ^a   Akhoundsadegh, Noushin ^a   Granville, David J ^a   Shapiro, Jerry ^b   McElwee, Kevin J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; CORTICOTROPIN; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 8; INTERLEUKIN 8 RECEPTOR 1; INTERLEUKIN RECEPTOR; TROPONIN I; UNCLASSIFIED DRUG;

ALOPECIA AREATA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; C3H MOUSE; CARDIOVASCULAR DISEASE; COLLAGEN IA1 GENE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE; GENE EXPRESSION REGULATION; HEART ATRIUM ENLARGEMENT; HEART VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; MOUSE; NONHUMAN; ORGAN WEIGHT; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION;

ACUTE DISEASE; ADRENOCORTICOTROPIC HORMONE; ALOPECIA AREATA; ANIMALS; CARDIOMEGALY; CHRONIC DISEASE; COLLAGEN; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION; HAIR FOLLICLE; HEART ATRIA; HEART VENTRICLES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-18; INTERLEUKIN-18 RECEPTOR ALPHA SUBUNIT; MICE; MICE, INBRED C3H; TISSUE CULTURE TECHNIQUES; TROPONIN I;

MURINAE; MUS;

EID: 84876822112     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062935     Document Type: Article

References (94)

1. Wang E, McElwee KJ, (2011) Etiopathogenesis of alopecia areata: Why do our patients get it? Dermatol Ther 24: 337-347.
2. Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J (2010) Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol 62: 177-188, quiz 189-190.
3. Petukhova L, Cabral RM, Mackay-Wiggan J, Clynes R, Christiano AM, (2011) The genetics of alopecia areata: What's new and how will it help our patients? Dermatol Ther 24: 326-336.
4. Kasumagic-Halilovic E, (2008) Thyroid autoimmunity in patients with alopecia areata. Acta Dermatovenerol Croat 16: 123-125.
5. Alikhan A, Felsten LM, Daly M, Petronic-Rosic V, (2011) Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J Am Acad Dermatol 65: 473-491.
6. Oiso N, Suzuki T, Fukai K, Katayama I, Kawada A, (2011) Nonsegmental vitiligo and autoimmune mechanism. Dermatol Res Pract 2011: 518090.
7. Chu SY, Chen YJ, Tseng WC, Lin MW, Chen TJ, et al. (2011) Comorbidity profiles among patients with alopecia areata: The importance of onset age, a nationwide population-based study. J Am Acad Dermatol.
8. Sharma VK, Dawn G, Kumar B, (1996) Profile of alopecia areata in Northern India. Int J Dermatol 35: 22-27.
9. Tsai TF, Wang TS, Hung ST, Tsai PI, Schenkel B, et al. (2011) Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan. J Dermatol Sci 63: 40-46.
10. Chu SY, Chen YJ, Tseng WC, Lin MW, Chen TJ, et al. (2012) Psychiatric comorbidities in patients with alopecia areata in Taiwan: a case-control study. Br J Dermatol 166: 525-531.
11. Ito N, Ito T, Kromminga A, Bettermann A, Takigawa M, et al. (2005) Human hair follicles display a functional equivalent of the hypothalamic-pituitary-adrenal axis and synthesize cortisol. FASEB J 19: 1332-1334.
12. Manolache L, Benea V, (2007) Stress in patients with alopecia areata and vitiligo. J Eur Acad Dermatol Venereol 21: 921-928.
13. Zhang X, Yu M, Yu W, Weinberg J, Shapiro J, et al. (2009) Development of alopecia areata is associated with higher central and peripheral hypothalamic-pituitary-adrenal tone in the skin graft induced C3H/HeJ mouse model. J Invest Dermatol 129: 1527-1538.
14. Guo HW, Deng J, Yang XC, Yang SY, Liu BH, et al. (2011) An implication for post-transcriptional control: reciprocal changes of melanocortin receptor type 2 mRNA and protein expression in alopecia areata. Med Hypotheses 76: 122-124.
15. Black PH, Garbutt LD, (2002) Stress, inflammation and cardiovascular disease. J Psychosom Res 52: 1-23.
16. Stojanovich L, Marisavljevich D, (2008) Stress as a trigger of autoimmune disease. Autoimmun Rev 7: 209-213.
17. Evers AW, Verhoeven EW, Kraaimaat FW, de Jong EM, de Brouwer SJ, et al. (2010) How stress gets under the skin: cortisol and stress reactivity in psoriasis. Br J Dermatol 163: 986-991.
18. Vena GA, Vestita M, Cassano N, (2010) Psoriasis and cardiovascular disease. Dermatol Ther 23: 144-151.
19. Eliakim-Raz N, Shuvy M, Lotan C, Planer D, (2008) Psoriasis and dilated cardiomyopathy: coincidence or associated diseases? Cardiology 111: 202-206.
20. Bauml MA, Underwood DA, (2010) Left ventricular hypertrophy: an overlooked cardiovascular risk factor. Cleve Clin J Med 77: 381-387.
21. Lorell BH, Carabello BA, (2000) Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation 102: 470-479.
22. Duprez D, De Buyzere M, Paelinck M, Rubens R, Dhooge W, et al. (1999) Relationship between left ventricular mass index and 24-h urinary free cortisol and cortisone in essential arterial hypertension. J Hypertens 17: 1583-1588.
23. Lang D, Muhler E, Kupferschmid C, Tacke E, von Bernuth G, (1984) Cardiac hypertrophy secondary to ACTH treatment in children. Eur J Pediatr 142: 121-125.
24. Pala M, Cassisa L, Di Girolamo G, Mameli P, Malavasi A, et al. (1998) [Hypertrophic cardiomyopathy during adrenocorticotrophic hormone administration in infants: a case report]. Cardiologia 43: 1375-1378.
25. Ro BI, (1995) Alopecia areata in Korea (1982-1994). J Dermatol 22: 858-864.
26. Walsh D, (1913) Circulatory Disorders In Relation To Baldness. The British Medical Journal 2: 1007-1011.
27. McElwee KJ, Boggess D, King LE Jr, Sundberg JP, (1998) Experimental induction of alopecia areata-like hair loss in C3H/HeJ mice using full-thickness skin grafts. J Invest Dermatol 111: 797-803.
28. Yu M, Zloty D, Cowan B, Shapiro J, Haegert A, et al. (2008) Superficial, nodular, and morpheiform basal-cell carcinomas exhibit distinct gene expression profiles. J Invest Dermatol 128: 1797-1805.
29. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
30. Ivandic BT, Qiao JH, Machleder D, Liao F, Drake TA, et al. (1996) A locus on chromosome 7 determines myocardial cell necrosis and calcification (dystrophic cardiac calcinosis) in mice. Proc Natl Acad Sci U S A 93: 5483-5488.
31. Aherrahrou Z, Axtner SB, Kaczmarek PM, Jurat A, Korff S, et al. (2004) A locus on chromosome 7 determines dramatic up-regulation of osteopontin in dystrophic cardiac calcification in mice. Am J Pathol 164: 1379-1387.
32. Meng H, Vera I, Che N, Wang X, Wang SS, et al. (2007) Identification of Abcc6 as the major causal gene for dystrophic cardiac calcification in mice through integrative genomics. Proc Natl Acad Sci U S A 104: 4530-4535.
33. Leite SN, Jordao Junior AA, Andrade TA, Masson Ddos S, Frade MA, (2011) Experimental models of malnutrition and its effect on skin trophism. An Bras Dermatol 86: 681-688.
34. O'Shaughnessy PJ, Fleming LM, Jackson G, Hochgeschwender U, Reed P, et al. (2003) Adrenocorticotropic hormone directly stimulates testosterone production by the fetal and neonatal mouse testis. Endocrinology 144: 3279-3284.
35. Hirobe T, Abe H, (2000) ACTH(4-12) is the minimal message sequence required to induce the differentiation of mouse epidermal melanocytes in serum-free primary culture. J Exp Zool 286: 632-640.
36. Brade T, Kumar S, Cunningham TJ, Chatzi C, Zhao X, et al. (2011) Retinoic acid stimulates myocardial expansion by induction of hepatic erythropoietin which activates epicardial Igf2. Development 138: 139-148.
37. Wen XL, Villee DB, Ellison P, Todd R, Loring J, (1985) Effects of adrenocorticotropic hormone, human chorionic gonadotropin, and insulin on steroid production by human adrenocortical carcinoma cells in culture. Cancer Res 45: 3974-3978.
38. Chang AN, Parvatiyar MS, Potter JD, (2008) Troponin and cardiomyopathy. Biochem Biophys Res Commun 369: 74-81.
39. Nellessen U, Goder S, Schobre R, Abawi M, Hecker H, et al. (2006) Serial analysis of troponin I levels in patients with ischemic and nonischemic dilated cardiomyopathy. Clin Cardiol 29: 219-224.
40. Miller WL, Hartman KA, Burritt MF, Grill DE, Rodeheffer RJ, et al. (2007) Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time. Circulation 116: 249-257.
41. Lim W, Cook DJ, Griffith LE, Crowther MA, Devereaux PJ (2006) Elevated cardiac troponin levels in critically ill patients: prevalence, incidence, and outcomes. Am J Crit Care 15: 280-288; quiz 289.
42. Sharma S, Jackson PG, Makan J, (2004) Cardiac troponins. J Clin Pathol 57: 1025-1026.
43. Searle J, Danne O, Muller C, Mockel M, (2011) Biomarkers in acute coronary syndrome and percutaneous coronary intervention. Minerva Cardioangiol 59: 203-223.
44. Park HJ, Kim HJ, Lee JY, Cho BK, Gallo RL, et al. (2007) Adrenocorticotropin hormone stimulates interleukin-18 expression in human HaCaT keratinocytes. J Invest Dermatol 127: 1210-1216.
45. Sekiyama A, Ueda H, Kashiwamura S, Nishida K, Kawai K, et al. (2005) IL-18; a cytokine translates a stress into medical science. J Med Invest 52Suppl: 236-239.
46. Sekiyama A, Ueda H, Kashiwamura S, Sekiyama R, Takeda M, et al. (2005) A stress-induced, superoxide-mediated caspase-1 activation pathway causes plasma IL-18 upregulation. Immunity 22: 669-677.
47. Arias-Santiago S, Gutierrez-Salmeron MT, Buendia-Eisman A, Giron-Prieto MS, Naranjo-Sintes R, (2010) Hypertension and aldosterone levels in women with early-onset androgenetic alopecia. Br J Dermatol 162: 786-789.
48. Gutersohn T, Scheidegger EP, (2005) Is baldness bad for the heart? Dermatology 211: 72-74.
49. Ahouansou S, Le Toumelin P, Crickx B, Descamps V, (2007) Association of androgenetic alopecia and hypertension. Eur J Dermatol 17: 220-222.
50. Arias-Santiago S, Gutierrez-Salmeron MT, Castellote-Caballero L, Buendia-Eisman A, Naranjo-Sintes R, (2010) Androgenetic alopecia and cardiovascular risk factors in men and women: a comparative study. J Am Acad Dermatol 63: 420-429.
51. Potier M, Karl M, Elliot SJ, Striker GE, Striker LJ, (2003) Response to sex hormones differs in atherosclerosis-susceptible and-resistant mice. Am J Physiol Endocrinol Metab 285: E1237-1245.
52. Porrello ER, Widdop RE, Delbridge LM, (2008) Early origins of cardiac hypertrophy: does cardiomyocyte attrition programme for pathological 'catch-up' growth of the heart? Clin Exp Pharmacol Physiol 35: 1358-1364.
53. Van Kerckhoven R, Kalkman EA, Saxena PR, Schoemaker RG, (2000) Altered cardiac collagen and associated changes in diastolic function of infarcted rat hearts. Cardiovasc Res 46: 316-323.
54. Biernacka A, Frangogiannis NG, (2011) Aging and Cardiac Fibrosis. Aging Dis 2: 158-173.
55. Park JB, Schiffrin EL, (2002) Cardiac and vascular fibrosis and hypertrophy in aldosterone-infused rats: role of endothelin-1. Am J Hypertens 15: 164-169.
56. Souders CA, Bowers SL, Baudino TA, (2009) Cardiac fibroblast: the renaissance cell. Circ Res 105: 1164-1176.
57. Rummery NM, McKenzie KU, Whitworth JA, Hill CE, (2002) Decreased endothelial size and connexin expression in rat caudal arteries during hypertension. J Hypertens 20: 247-253.
58. Madri JA, Pratt BM, Yannariello-Brown J, (1988) Matrix-driven cell size change modulates aortic endothelial cell proliferation and sheet migration. Am J Pathol 132: 18-27.
59. Mustonen E, Aro J, Puhakka J, Ilves M, Soini Y, et al. (2008) Thrombospondin-4 expression is rapidly upregulated by cardiac overload. Biochem Biophys Res Commun 373: 186-191.
60. Gerdes N, Sukhova GK, Libby P, Reynolds RS, Young JL, et al. (2002) Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis. J Exp Med 195: 245-257.
61. Dinarello CA, (2001) Novel targets for interleukin 18 binding protein. Ann Rheum Dis 60Suppl 3: iii18-24.
62. Chandrasekar B, Mummidi S, Claycomb WC, Mestril R, Nemer M, (2005) Interleukin-18 is a pro-hypertrophic cytokine that acts through a phosphatidylinositol 3-kinase-phosphoinositide-dependent kinase-1-Akt-GATA4 signaling pathway in cardiomyocytes. J Biol Chem 280: 4553-4567.
63. Woldbaek PR, Sande JB, Stromme TA, Lunde PK, Djurovic S, et al. (2005) Daily administration of interleukin-18 causes myocardial dysfunction in healthy mice. Am J Physiol Heart Circ Physiol 289: H708-714.
64. Mallat Z, Heymes C, Corbaz A, Logeart D, Alouani S, et al. (2004) Evidence for altered interleukin 18 (IL)-18 pathway in human heart failure. Faseb J 18: 1752-1754.
65. Wang M, Markel TA, Meldrum DR, (2008) Interleukin 18 in the heart. Shock 30: 3-10.
66. Wang SF, Xu JC, Liang QX, (2006) [Levels of plasma interleukin-18 and interferon-gamma in patients with coronary heart disease]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 18: 237-239.
67. Baran W, Szepietowski JC, Mazur G, Baran E, (2008) IFN-gamma promoter gene polymorphism in psoriasis vulgaris. Biomarkers 13: 52-58.
68. Dinarello CA, (2007) Interleukin-18 and the pathogenesis of inflammatory diseases. Semin Nephrol 27: 98-114.
69. Dinarello CA, (1999) IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 103: 11-24.
70. Xiang Y, Moss B, (1999) IL-18 binding and inhibition of interferon gamma induction by human poxvirus-encoded proteins. Proc Natl Acad Sci U S A 96: 11537-11542.
71. Luan Y, Guo Y, Li S, Yu B, Zhu S, et al. (2010) Interleukin-18 among atrial fibrillation patients in the absence of structural heart disease. Europace 12: 1713-1718.
72. Jefferis BJ, Papacosta O, Owen CG, Wannamethee SG, Humphries SE, et al. (2011) Interleukin 18 and coronary heart disease: prospective study and systematic review. Atherosclerosis 217: 227-233.
73. Naito Y, Tsujino T, Fujioka Y, Ohyanagi M, Okamura H, et al. (2002) Increased circulating interleukin-18 in patients with congestive heart failure. Heart 88: 296-297.
74. Holzinger C, Schollhammer A, Imhof M, Reinwald C, Kramer G, et al. (1995) Phenotypic patterns of mononuclear cells in dilated cardiomyopathy. Circulation 92: 2876-2885.
75. Liao CH, Akazawa H, Tamagawa M, Ito K, Yasuda N, et al. (2010) Cardiac mast cells cause atrial fibrillation through PDGF-A-mediated fibrosis in pressure-overloaded mouse hearts. J Clin Invest 120: 242-253.
76. Platis A, Yu Q, Moore D, Khojeini E, Tsau P, et al. (2008) The effect of daily administration of IL-18 on cardiac structure and function. Perfusion 23: 237-242.
77. Fix C, Bingham K, Carver W, (2011) Effects of interleukin-18 on cardiac fibroblast function and gene expression. Cytokine 53: 19-28.
78. Johansen C, Moeller K, Kragballe K, Iversen L, (2007) The activity of caspase-1 is increased in lesional psoriatic epidermis. J Invest Dermatol 127: 2857-2864.
79. Dinarello CA, (2011) Blocking interleukin-1beta in acute and chronic autoinflammatory diseases. J Intern Med 269: 16-28.
80. Dos Santos JC, Azor MH, Nojima VY, Lourenco FD, Prearo E, et al. (2008) Increased circulating pro-inflammatory cytokines and imbalanced regulatory T-cell cytokines production in chronic idiopathic urticaria. Int Immunopharmacol 8: 1433-1440.
81. Lee D, Hong SK, Park SW, Hur DY, Shon JH, et al. (2010) Serum levels of IL-18 and sIL-2R in patients with alopecia areata receiving combined therapy with oral cyclosporine and steroids. Exp Dermatol 19: 145-147.
82. Adams JE 3rd, Bodor GS, Davila-Roman VG, Delmez JA, Apple FS, et al (1993) Cardiac troponin I. A marker with high specificity for cardiac injury. Circulation 88: 101-106.
83. Babuin L, Jaffe AS, (2005) Troponin: the biomarker of choice for the detection of cardiac injury. Cmaj 173: 1191-1202.
84. Ito H, Hiroe M, Hirata Y, Tsujino M, Adachi S, et al. (1993) Insulin-like growth factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes. Circulation 87: 1715-1721.
85. Guo HW, Deng J, Yang XC, Zhong BY, Shen Z, et al. (2011) Melanocortin receptor type 2 (MC2R, ACTH receptor) expression in patients with alopecia areata. Exp Dermatol 19: 1020-1022.
86. Otis M, Campbell S, Payet MD, Gallo-Payet N, (2007) Expression of extracellular matrix proteins and integrins in rat adrenal gland: importance for ACTH-associated functions. J Endocrinol 193: 331-347.
87. Kahai S, Vary CP, Gao Y, Seth A, (2004) Collagen, type V, alpha1 (COL5A1) is regulated by TGF-beta in osteoblasts. Matrix Biol 23: 445-455.
88. Evans JF, Fernando A, Ragolia L, (2012) Functional melanocortin-2 receptors are expressed by mouse aorta-derived mesenchymal progenitor cells. Mol Cell Endocrinol 355: 60-70.
89. Isales CM, Zaidi M, Blair HC, (2010) ACTH is a novel regulator of bone mass. Ann N Y Acad Sci 1192: 110-116.
90. Wenstrup RJ, Florer JB, Brunskill EW, Bell SM, Chervoneva I, et al. (2004) Type V collagen controls the initiation of collagen fibril assembly. J Biol Chem 279: 53331-53337.
91. Caulfield JB, Janicki JS, (1997) Structure and function of myocardial fibrillar collagen. Technol Health Care 5: 95-113.
92. Vogelzangs N, Beekman AT, Milaneschi Y, Bandinelli S, Ferrucci L, et al. (2010) Urinary cortisol and six-year risk of all-cause and cardiovascular mortality. J Clin Endocrinol Metab 95: 4959-4964.
93. Jokinen J, Nordstrom P, (2009) HPA axis hyperactivity and cardiovascular mortality in mood disorder inpatients. J Affect Disord 116: 88-92.
94. Mizuno Y, Yasue H, Yoshimura M, Harada E, Fujii H, et al. (2005) Adrenocorticotropic hormone is produced in the ventricle of patients with essential hypertension. J Hypertens 23: 411-416.